4-[(5Z)-4-amino-5-(7-methoxyindol-2-ylidene)-1H-imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylic acid


Chemical Name: 4-[(5Z)-4-amino-5-(7-methoxyindol-2-ylidene)-1H-imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylic acid
CAS Number: 936890-98-1
Product Number: AG00GU56(AGN-PC-072XA4)
Synonyms:
MDL No:
Molecular Formula: C21H22N6O3
Molecular Weight: 406.4378

Identification/Properties


Computed Properties
Molecular Weight:
406.446g/mol
XLogP3:
2
Hydrogen Bond Donor Count:
3
Hydrogen Bond Acceptor Count:
7
Rotatable Bond Count:
4
Exact Mass:
406.175g/mol
Monoisotopic Mass:
406.175g/mol
Topological Polar Surface Area:
131A^2
Heavy Atom Count:
30
Formal Charge:
0
Complexity:
630
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



OSI-027 is a potent and selective dual inhibitor of the mammalian target of rapamycin (mTOR) kinase and the AKT kinase, both of which are key regulators of cell growth, proliferation, survival, and metabolism. In chemical synthesis, OSI-027 plays a crucial role as a tool compound for studying the phosphorylation cascades involved in cellular processes.mTOR and AKT are essential components of the PI3K/AKT/mTOR signaling pathway, which is frequently dysregulated in various cancer types and other diseases. By inhibiting both mTOR and AKT, OSI-027 can provide valuable insights into the mechanisms by which these kinases regulate cellular functions and help uncover potential therapeutic targets for drug development.Additionally, OSI-027 can be utilized in chemical biology and drug discovery research to investigate the role of mTOR and AKT in various signaling pathways within the cell. Its ability to selectively target these kinases makes OSI-027 a valuable tool for elucidating the intricate interplay between different signaling molecules and pathways, enabling researchers to better understand the underlying molecular mechanisms of diseases and potentially identify novel therapeutic interventions.